Komen Wisconsin's More Than Pink Walk is coming up on Sunday, Sept. 28.It's a chance to come together to connect and raise live-saving funds for the fight against breast cancer.
A promising new PET tracer can visualize a protein that is commonly overexpressed in triple-negative breast and urothelial ...
Scientists are reprogramming how T cells work so they can fight against tumors, "turning them from cancer protectors into ...
Either fight or give up.” That was the choice Columbus resident Angelica Ouk faced when she was diagnosed with triple ...
A promising new PET tracer can visualize a protein that is commonly overexpressed in triple-negative breast and urothelial bladder cancers within four hours, according to research published in the ...
New research by the IU School of Medicine is looking at new ways to fight aggressive cancers. Right now the focus is on ...
A promising new PET tracer can visualize a protein that is commonly overexpressed in triple-negative breast and ...
Inoviq Ltd ( ($AU:IIQ) ) has shared an announcement. INOVIQ Ltd announced positive results from in vitro studies of its CAR-NK-exosome therapeutic ...
How to navigate an early-in-life diagnosis, from fertility concerns to career questions When most people picture someone ...
The Company's application to European regulators has been formally approved, adding Ireland as an approved country in FLAMINGO-01 in addition to Spain, France, Germany, Italy, Poland, Romania, and the ...
Quanyin Hu, a professor in the University of Wisconsin-Madison School of Pharmacy, spoke to The Daily Cardinal about his ...
Signals from a Phase Ia trial of LP-184 in solid tumors suggested that patients with DNA damage response gene mutations might respond well to the drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results